Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pathogen adhesins and lectins are specialized surface molecules, primarily proteins, that mediate the attachment of microorganisms—including bacteria, viruses, and fungi—to host cell surfaces or the extracellular matrix [PubMed: 28257055]. Adhesins often constitute the tips of pili or fimbriae, while lectins are a specific class of adhesins that recognize and bind to complex carbohydrate structures (glycans) on host tissues [PubMed: 29233510]. This molecular recognition is the essential first step for colonization, tissue invasion, and the establishment of infection, as well as the formation of protective biofilms [PubMed: 31515370]. Because these interactions are highly specific, they represent attractive targets for anti-adhesion therapies, which aim to block the initial docking of the pathogen rather than exerting bactericidal or virucidal pressure. Therapeutic strategies include the use of glycomimetics, such as mannosides targeting the FimH adhesin in uropathogenic E. coli, and monoclonal antibodies that neutralize viral attachment proteins [PubMed: 31515370, PubMed: 28257055]. These approaches are particularly valuable in the context of rising antimicrobial resistance, as they may reduce the evolutionary pressure for pathogens to develop traditional resistance mechanisms.
Competitive inhibition of pathogen-host binding to prevent colonization and infection.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogen adhesins and lectins.